ASHPOfficial

ASHPOfficial

By American Society of Health-System Pharmacists©ScienceMedicineHealth & Fitness
Download on the App Store

ASHPOfficial episodes

  • Student Perspectives: COVID-19 Impact on Student Societies
    Today on ASHPOfficial, we chat with student leaders across the nation about their perspectives on the COVID-19 pandemic. In this podcast, we will dive into how students are adapting to the virtual learning model and how student societies are coping with the changing environment.  The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
    42 min
  • Student Perspectives: COVID-19 Impact on Student Societies
    Today on ASHPOfficial, we chat with student leaders across the nation about their perspectives on the COVID-19 pandemic. In this podcast, we will dive into how students are adapting to the virtual learning model and how student societies are coping with the changing environment.  
    The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
    42 min
  • COVID-19: Remdesivir: Early Use in Search for its Niche
    Remdesivir has been added to the FDA Emergency Use Authorization list for the treatment of hospitalized patients with severe COVID-19 disease. As such, pharmacists may have questions about the practical and operational aspects of the procurement and utilization of this medication.  This podcast focuses on investigational drug services, dose conservation, and clinical experiences with remdesivir.  In order to learn more about early information on the clinical use of and access to Remdesivir for the treatment of patients with COVID-19, please see the full webinar recording at ASHP elearning.org.*Recorded on 5/13The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
    18 min
  • COVID-19: Remdesivir: Early Use in Search for its Niche
    Remdesivir has been added to the FDA Emergency Use Authorization list for the treatment of hospitalized patients with severe COVID-19 disease. As such, pharmacists may have questions about the practical and operational aspects of the procurement and utilization of this medication.  This podcast focuses on investigational drug services, dose conservation, and clinical experiences with remdesivir.  In order to learn more about early information on the clinical use of and access to Remdesivir for the treatment of patients with COVID-19, please see the full webinar recording at ASHP elearning.org.
    *Recorded on 5/13
    The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
    18 min
  • Advocating for Impact: Deciphering CMS’s Telehealth Changes
    Jillanne Schulte Wall, ASHP Senior Director, Health & Regulatory Policy and Mary Ann Kliethermes, ASHP Director, Medication Safety & Quality, discuss CMS’s recent telehealth changes, the resulting regulatory flexibilities that are helpful to our members and their patients, and ASHP’s next steps on telehealth advocacy.
    The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
    41 min
  • Advocating for Impact: Deciphering CMS’s Telehealth Changes
    Jillanne Schulte Wall, ASHP Senior Director, Health & Regulatory Policy and Mary Ann Kliethermes, ASHP Director, Medication Safety & Quality, discuss CMS’s recent telehealth changes, the resulting regulatory flexibilities that are helpful to our members and their patients, and ASHP’s next steps on telehealth advocacy.The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
    41 min
  • From the Frontline of COVID-19: Clinician Perspectives on Cytokine Storm
    ASHP sits down with Dr. Jill Starykowicz, PharmD, BCCCP, Clinical Pharmacy Specialist, Medical/ Cardiac Intensive Care Unit and Director, PGY2 Critical Care Pharmacy Residency at Advocate Lutheran General Hospital in Park Ridge, Illinois as she discusses cytokine storm in critically ill COVID-19 patients. 
    The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician
    12 min
  • From the Frontline of COVID-19: Clinician Perspectives on Cytokine Storm

    ASHP sits down with Dr. Jill Starykowicz, PharmD, BCCCP, Clinical Pharmacy Specialist, Medical/ Cardiac Intensive Care Unit and Director, PGY2 Critical Care Pharmacy Residency at Advocate Lutheran General Hospital in Park Ridge, Illinois as she discusses cytokine storm in critically ill COVID-19 patients. 

    The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician

     

    12 min
  • From the Frontline of COVID-19: Clinician Perspectives on Anticoagulation
    We chat with Michael Gulseth about the unique aspects of treating COVID-19 patients that present with coagulopathies. Assessing risk of thromboembolism and anticoagulation strategies in these patients will also be discussed.The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
    24 min
  • From the Frontline of COVID-19: Clinician Perspectives on Anticoagulation

    We chat with Michael Gulseth about the unique aspects of treating COVID-19 patients that present with coagulopathies. Assessing risk of thromboembolism and anticoagulation strategies in these patients will also be discussed.

    The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

    24 min

About ASHPOfficial

From the publisher's feed

ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings,…

More shows like ASHPOfficial

Motley Fool Hidden Gems Investing by The Motley Fool

Motley Fool Hidden Gems Investing

3,154 Listeners

The Daily by The New York Times

The Daily

111,852 Listeners

Up First from NPR by NPR

Up First from NPR

56,426 Listeners

Giggly Squad by Hannah Berner & Paige DeSorbo

Giggly Squad

15,408 Listeners